Vergara, A. Z., Carreño, G., Marin, F. F., Xicoy, B., Casares, M. T. G., Sánchez-Guijo, F., Nuño, M. C. R., Prendes, S. O., Paz, R. D., Mas, A. I. R., Casterá, E. M., Senin, M. A., Boluda, J. C. H., Diaz, R. A., Gutiérrez, V. G., Lopez, J. M. (2025). Ponatinib as a consolidation strategy for a second attempt at TKI discontinuation in chronic myeloid leukemia: Interim results from the restop Trial. Blood. https://doi.org/10.1182/blood-2025-3778